shared a post on LinkedIn:
“Guideline update, Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer, is now available. Recommendations include that routine SLNB is not recommended for postmenopausal, ≥50-year-old patients with grade 1-2, ≤2cm, HR+/HER2- breast cancer and negative axillary ultrasound, undergoing breast-conserving therapy.”